Advertisement

Topics

Sandoz Gets European Commission Approval For Zessly

01:37 EDT 24 May 2018 | FinanzNachrichten

BASEL (dpa-AFX) - Sandoz, a Novartis (NVS) division, said Thursday that the European Commission has approved Zessly or infliximab for use in Europe.Zessly is approved for use in all indications of...

Original Article: Sandoz Gets European Commission Approval For Zessly

NEXT ARTICLE

More From BioPortfolio on "Sandoz Gets European Commission Approval For Zessly"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...